Long-read sequencing technologies generate reads exceeding 10kb enabling accurate genome assembly, structural variant detection, and complex repeat resolution beyond short-read limitations. This market research report analyzes drivers, challenges, detailed segments, and top players based exclusively on Straits Research insights for genomic research strategy.

Market Size

The long-read sequencing market size was valued at USD 645.00 million in 2025 and is projected to grow from USD 772.46 million in 2026 to USD 3347.63 million by 2034 at a CAGR of 20.12% during the forecast period (2026-2034), as per Straits Research Analysis. 

Get Your Sample Report Here: https://straitsresearch.com/report/long-read-sequencing-market/request-sample

Market Drivers

Researchers seek contiguous genome assemblies resolving repetitive regions missed by short-read technologies. Healthcare focuses personalized treatment requiring structural variant and haplotype detection.

Multi-omics integration combines genomics with transcriptomics and epigenomics using long-read direct RNA sequencing. Government funding expands sequencing infrastructure supporting method development.

Intellectual property protection demands high-resolution genomic evidence for patent validation. Cell and gene therapy commercialization requires genomic quality control verification.

Market Challenges

High instrument and reagent costs restrict resource-limited labs. Complex data analysis demands specialized bioinformatics infrastructure.

Earlier platforms showed higher base error rates limiting diagnostic applications. Large datasets require high-performance computing and skilled interpretation.

Market Segments

By Product

Consumables dominate 60.23% share with recurring reagents, flow cells, and library kits. Instruments enable high-throughput platforms.

Services grow 21.23% CAGR through contract sequencing and bioinformatics support.

By Technology

Nanopore sequencing leads 58.83% share with real-time portability for field genomics. Single-molecule real-time sequencing grows 21.56% CAGR for structural variant accuracy.

By Workflow

Sequencing commands 63.18% share as core revenue generator. Data analysis accelerates 21.87% CAGR with AI genomic interpretation.

Pre-sequencing optimizes library preparation.

By Application

Whole genome sequencing holds 31.13% share resolving complex regions. Metagenomics grows 21.88% CAGR for microbiome research.

RNA sequencing, epigenetics, targeted sequencing expand utility.

By End Use

Academic institutes dominate 50.23% share for fundamental research. Pharma/biotech grows 21.92% CAGR for drug discovery.

Hospitals/clinics integrate clinical genomics.

By Region

North America leads 53.82% share through federal programs. Asia Pacific grows 22.12% CAGR via national genomics initiatives.

Europe develops federated data infrastructure. Middle East/Africa addresses genomic diversity gaps. Latin America advances public health genomics.

Obtain Long-read Sequencing Strategic Report: https://straitsresearch.com/buy-now/long-read-sequencing-market

Top Players Analysis

1. Oxford Nanopore Technologies Limited: PromethION delivers ultra-long reads for metagenomics. Portable MinION enables field sequencing.

2. Quantapore, Inc.: Nanopore innovations target structural variants. High-throughput platform development.

3. Agilent Technologies: Long-read compatible library prep kits. Co-marketing partnerships expand ecosystem.

4. Element Biosciences: AVITI system integrates long-read capabilities. Cost-competitive sequencing solutions.

5. BGI: Complete Genomics division advances long-read assembly. Large-scale population genomics expertise.

6. Eurofins Genomics: Service provider integrates long-read workflows. Clinical research applications.

7. Hoffmann-La Roche Ltd.: Stratos Genomics acquisition strengthens portfolio. Precision medicine focus.

8. MicrobesNG: Metagenomics service leverages long-read resolution. Environmental genomics specialist.

9. Takara Bio: Library preparation kits optimize long-read input. Cloning technology synergies.

10. New England Biolabs: Enzymatic solutions enhance long-read quality. Molecular biology reagents leadership.

About Us

Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com